-
Study aim
-
Determining the effect of the capsule (cumin, dill, and fennel) on postpartum pain
-
Design
-
The clinical trial has control and intervention group, three-way blind, randomized, on 100 patients by Excel software
-
Settings and conduct
-
The intervention is performed in the postpartum ward of Shohadae 15 Khordad Hospital in Varamin, in two groups. According to the ward’s regulation, women receive a 250 mg mefenamic acid capsule. In addition to the mefenamic acid capsule, one capsule (cumin, dill, and dill)/placebo will be given. For blinding, the intervention is performed by a researcher (midwife with similar work experience).
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Normal vaginal delivery, Gestational age 37-42 weeks, Live child,Weight of baby born between 2500-4000 grams, Moderate or severe postpartum pain.
Exclusion criteria: Severe bleeding, grade 3 or 4 of perineal rupture, History of allergies to medicinal plants
-
Intervention groups
-
Herbs (cumin, dill, and fennel) will be purchased and after approving the identification, by soaking in ethanol alcohol at 96 degrees method, they will be extracted. Then the plant extraction (cumin, dill, and fennel) will be mixed with corn starch and filled in 500 mg capsules. Each capsule contains 300 mg prepared extraction from 100 mg of each plant extract .The placebo capsule contains dry bread and will be prescribed in a similar dose and capsule in the control group. These capsules are prescribed every 8 hours, 2 to 24 hours after normal delivery for mothers who meet the inclusion criteria and are categorized in the Intervention and control groups.
-
Main outcome variables
-
Severity and duration, and time of postpartum pain relief